T cell Activation

T cell activation is a crucial checkpoint in adaptive immunity, and this activation depends on the binding parameters that govern the interactions between T cell receptors and peptide-MHC complexes. Here is the latest research.

July 10, 2020
Open Access

Immunological and inflammatory profiles in mild and severe cases of COVID-19

Nature Communications
Jin-Wen SongJi-Yuan Zhang
July 10, 2020
Preprint

Programming Multifaceted Pulmonary T-Cell Immunity by Combination Adjuvants

BioRxiv : the Preprint Server for Biology
July 12, 2020

Activation of Human Vδ2+ γδ T Cells by Staphylococcus aureus Promotes Enhanced Anti-Staphylococcal Adaptive Immunity

The Journal of Immunology : Official Journal of the American Association of Immunologists
Andrew J R CooperRachel M McLoughlin
July 15, 2020

Increasing the expression of programmed death ligand 2 (PD-L2) but not 4-1BB ligand in colorectal cancer cells

Molecular Biology Reports
Parastoo ShakerinMaryam Nourizadeh
July 11, 2020

Reappearance of effector T cells is associated with recovery from COVID-19

EBioMedicine
Ivan OdakChristian R Schultze-Florey
July 12, 2020
Review

Regulatory T Cell Metabolism in Atherosclerosis

Metabolites
Jeroen Baardman, Esther Lutgens
July 10, 2020
Preprint

Mapping the evolution of T cell states during response and resistance to adoptive cellular therapy

BioRxiv : the Preprint Server for Biology
July 14, 2020
Preprint

A population of CD4+ T cells with a naive phenotype stably polarized to the TH1 lineage

BioRxiv : the Preprint Server for Biology
Graham M LoGraham M Lord
July 11, 2020

Redefining Memory T Cell Subsets

Trends in Immunology
Rod A Rahimi, Andrew D Luster
July 10, 2020

Rewired signaling network in T cells expressing the chimeric antigen receptor (CAR)

The EMBO Journal
Rui DongXiaolei Su
July 11, 2020
Review

Autoimmune gastritis

Nature Reviews. Disease Primers
Marco Vincenzo LentiAntonio Di Sabatino
July 10, 2020

Metformin and 2-Deoxyglucose Collaboratively Suppress Human CD4+ T Cell Effector Functions and Activation-Induced Metabolic Reprogramming

The Journal of Immunology : Official Journal of the American Association of Immunologists
Stefanie Y TanJ Perry Hall
July 12, 2020

Dynamic palmitoylation events following T-cell receptor signaling

Communications Biology
Eliot MorrisonChristian Freund
July 10, 2020
Open Access

T Cell Metabolism in Cancer Immunotherapy

Immunometabolism
Halil-Ibrahim AksoylarNikolaos Patsoukis
July 15, 2020

Neuropilin-1 is a T cell memory checkpoint limiting long-term antitumor immunity

Nature Immunology
Chang LiuDario A A Vignali

Sign up to follow this feed and discover related papers.

Related Feeds

Antibodies: Agglutination

Antibody-mediated agglutination is the clumping of cells in the presence of antibody, which binds multiple cells together. This enhances the clearance of pathogens. Find the latest research on antibody-mediated agglutination here.

Antibodies: Complement Activation

The complement system can be activated by antigen-associated antibody. In the classical pathway of complement activation, C1q, C4b, and C3b are all able to bind to the Fc portion of IgG or IgM. Find the latest research on antibodies and complement activation here.

Antibody Development

Development of antibodies require integration of knowledge with respect to target antigen properties, antibody design criteria such as affinity, isotype selection, Fc domain engineering, and antibody cross-reactivity across species from the early stages of antibody development. Here is the latest research.


Antibody Specificity

Antibodies produced by B cells are highly specific for antigen as a result of random gene recombination and somatic hypermutation and affinity maturation. As the main effector of the humoral immune system, antibodies can neutralize foreign cells. Find the latest research on antibody specificity here.

Antibody synthesis

Antibodies have various functions including neutralization of pathogens, tumor targeting, as well as its utility in biomedical research. Here is the latest research on antibody synthesis.

Antibody-Dependent Cell Cytotoxicity

Antibody-dependent cellular toxicity refers to the lysis of a target cell by a non-sensitized effector cell of the immune system as a result of antibodies binding to the target cell membrane and engaging the Fc receptors on the immune effector cells. Find the latest research on antibody-dependent cellular toxicity here.

Antibody-Dependent Enhancement

Antibody-dependent enhancement of viral infection is the entry of virus into host cells mediated by antiviral antibodies interacting with Fc or complement receptors. This has been most extensively observed with the dengue virus. Find the latest research on antibody-dependent enhancement here.

Antigenic Modulation

Antigenic modulation occurs when an antibody cross-links antigens on a cell surface, causing the antigens to become internalized. This can lead to therapeutic failure of monoclonal antibodies as the expression of the antigen becomes decreased on target cells. Find the latest research on antigenic modulation here.

B cell Activation

B cell activation is initiated by the ligation of the B cell receptor with antigen and ultimately results in the production of protective antibodies against potentially pathogenic invaders. Here is the latest research.

B cell Differentiation

Depending on the signal received through the B cell receptor and other receptors, B cells differentiate into follicular or marginal zone B cells. Here is the latest research pertaining to this differentiation process.

© 2020 Meta ULC. All rights reserved
/feed-previews/t-cell-activation/0c005bac-4fdf-489d-b13f-52bd4d60f2b9